86 related articles for article (PubMed ID: 3029252)
1. [Myelotoxicity due to cancer chemotherapy].
Nakamura S; Yoshida T; Ohtake S; Itoh K; Kobayashi K; Nakanishi J; Matsuda T; Natori H; Egami K
Nihon Gan Chiryo Gakkai Shi; 1986 Oct; 21(9):2196-205. PubMed ID: 3029252
[No Abstract] [Full Text] [Related]
2. [Dry extract of Scutellaria baicalensis as a hemostimulant in antineoplastic chemotherapy in patents with lung cancer].
Gol'dberg VE; Ryzhakov VM; Matiash MG; Stepovaia EA; Boldyshev DA; Litvinenko VI; Dygaĭ AM
Eksp Klin Farmakol; 1997; 60(6):28-30. PubMed ID: 9460593
[TBL] [Abstract][Full Text] [Related]
3. [Myelotoxicity due to cancer chemotherapy with special reference to autologous bone marrow transplantation].
Nakamura S
Gan No Rinsho; 1984 Jul; 30(9 Suppl):1195-202. PubMed ID: 6381786
[TBL] [Abstract][Full Text] [Related]
4. [The relation between myelotoxicity and performance status or aging in chemotherapy of non-small cell lung cancer].
Oshita F; Shinkai T; Miya T; Kojima A; Ohe Y; Tamura T; Sasaki Y; Eguchi K; Saijo N
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Feb; 29(2):231-8. PubMed ID: 1851904
[TBL] [Abstract][Full Text] [Related]
5. [Quantitative-kinetic aspects of granulocytic resistance to infection in hematologic systemic diseases with reference to antineoplastic chemotherapy].
Sommer S
Z Arztl Fortbild (Jena); 1988; 82(11):513-5. PubMed ID: 3176536
[No Abstract] [Full Text] [Related]
6. Treatment strategies in relation to drug action.
Muggia FM; McVie G
NCI Monogr; 1987; (4):129-33. PubMed ID: 2819724
[No Abstract] [Full Text] [Related]
7. [Lymphocyte subset change during cancer chemotherapy on patients with gastrointestinal, lung and hematopoietic malignancies].
Ohashi Y; Ito K; Nishi I; Kanko T; Nakao I; Nomura C; Aoki H; Saito T
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):475-81. PubMed ID: 2321977
[TBL] [Abstract][Full Text] [Related]
8. [Leukemic cell kill kinetics in bone marrow].
Ohmoto E; Takahashi I; Yorimitsu S; Hara M; Inagaki N; Nakada H; Aoyama S; Kimura I; Kitajima K; Sanada H
Rinsho Ketsueki; 1986 Sep; 27(9):1590-5. PubMed ID: 3806971
[No Abstract] [Full Text] [Related]
9. Cisplatin and etoposide combination chemotherapy for refractory small cell carcinoma of the lung.
Porter LL; Johnson DH; Hainsworth JD; Hande KR; Greco FA
Cancer Treat Rep; 1985 May; 69(5):479-81. PubMed ID: 2988773
[TBL] [Abstract][Full Text] [Related]
10. [Circulating hematopoietic stem cells in patients with small cell lung cancer].
Shimizu E; Mukai J; Nakamura Y; Nakanishi M; Sone S; Ogura T; Takaue Y; Watanabe T; Kawano Y
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3499-501. PubMed ID: 2552933
[No Abstract] [Full Text] [Related]
11. [The use of leukomax for potentiating combined chemotherapy of small cell lung cancer].
Gorbunova VA; Bychkov MB; Perevodchikova NI; Orel NF; Smirnova NB
Vopr Onkol; 1995; 41(1):72-4. PubMed ID: 7667948
[No Abstract] [Full Text] [Related]
12. Treatment intensification which includes high-dose induction improves survival of lung carcinoma patients treated by high-dose chemotherapy with hematopoietic progenitor cell rescue but does not prevent high rate of relapses.
Tomeczko J; Pacuszko T; Napora P; Lange A
Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S44-7. PubMed ID: 8899171
[No Abstract] [Full Text] [Related]
13. Cytogenetic damage in lymphocytes of patients undergoing therapy for small cell lung cancer and ovarian carcinoma.
Padjas A; Lesisz D; Lankoff A; Banasik A; Lisowska H; Bakalarz R; Góźdź S; Wojcik A
Toxicol Appl Pharmacol; 2005 Dec; 209(2):183-91. PubMed ID: 15885733
[TBL] [Abstract][Full Text] [Related]
14. Sodium and potassium excretion changes and bone marrow recovery after chemotherapy.
Kiss I; Tomasek J
Stem Cells; 1999; 17(4):233-4. PubMed ID: 10437987
[No Abstract] [Full Text] [Related]
15. In vitro evaluation of myelotoxicity induced by antineoplastic drugs.
Viano I; Silvestro L; Giaccone G; Compagnoni G; Donadio M; Ferrati P; Dianzani C; Genazzani E
Chemioterapia; 1986 Jun; 5(3):147-9. PubMed ID: 3013432
[TBL] [Abstract][Full Text] [Related]
16. [Malignant lymphoma following operation and chemotherapy of small cell lung carcinoma].
Yokoi M; Nagai T; Hirabayashi M; Okamura A; Tatsumi E; Nishikori M
Rinsho Ketsueki; 1993 Mar; 34(3):378-80. PubMed ID: 8386780
[TBL] [Abstract][Full Text] [Related]
17. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
Strauss GM; Lynch TJ; Elias AD; Jacobs C; Kwiatkowski DJ; Shulman LN; Carey RW; Grossbard ML; Jauss S; Sugarbaker DJ
Semin Oncol; 1995 Aug; 22(4 Suppl 9):70-4. PubMed ID: 7544029
[TBL] [Abstract][Full Text] [Related]
18. Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemia.
Shaklai S; Bairey O; Blickstein D; Prokocimer M; Hadar H; Lahav M; Sulkes J; Shaklai M
Cancer; 1996 Jun; 77(11):2313-7. PubMed ID: 8635101
[TBL] [Abstract][Full Text] [Related]
19. [Prevention of renal toxicity of cisplatin by administration of bismuth subnitrate].
Hamada T; Nishiwaki Y; Kodama T; Hayashibe A; Nukariya N; Sasaki H; Morikawa T; Hirosawa T; Matsuyama T
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3587-93. PubMed ID: 2554815
[TBL] [Abstract][Full Text] [Related]
20. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
Bozóky G; Ruby E; Góhér I; Gábor G; Mohos A; Lengyel M
Orv Hetil; 2005 Jul; 146(27):1433-8. PubMed ID: 16089103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
